Mead Johnson develops, manufactures, markets and distributes more than 70 products in 50 markets worldwide, primarily under the "Enfa" family of brands, including Enfamil® infant formula.
- Bennett to Announce New Growth Model
- State Reaches Settlement With CVS
- Deadline Nearing For National Idea to Product Contest
- DNR to Close Southern Indiana Campground
- Haynes Reports Q1 Loss
- IU Kokomo Narrows List of Chancellor Candidates
- MISCOR Sells Two Businesses
- Randolph County Dairy Files For Bankruptcy
- [UPDATED] ExactTarget Lands More High Profile Clients
updated: 3/13/2009 12:55:24 PM
Mead Johnson Expands Board of Directors
Evansville-based Mead Johnson Nutrition Company (NYSE: MJN) has announced two new members to its board of directors. Dr. Steven Altschuler is currently president and chief executive officer of The Children’s Hospital of Philadelphia. Dr. Elliott Sigal is the executive vice president, chief scientific officer and president, research and development for Bristol-Myers Squibb. Altschuler and Sigal bring the total number of Mead Johnson directors to 11.
Source: Inside INdiana Business
 Phil Ray, Omni Severin Indianapolis, General ManagerOmni Severin Indianapolis General Manager Phil Ray talks to Inside INdia... |
 Jonathan Weinzapfel, Mayor of EvansvilleIn a Studio(i) interview with Inside INdiana Business Host Gerry Dick, W... |
 Mike Peduto, Partner, Circle City TicketsIn a Studio(i) interview, Peduto talked about the demand for Colts ticke... |
FrontPg.jpg)
Press Release
Evansville, Ind. -- Mead Johnson Nutrition Company (NYSE: MJN) announced today that its board of directors has elected Steven M. Altschuler, M.D., and Elliott Sigal, M.D., Ph.D., to the board. The company said that these additions increase the size of its board to 11.
“We are pleased to have Dr. Altschuler and Dr. Sigal join our board of directors,” said James Cornelius, Mead Johnson Nutrition board chairman. “We’re looking forward to working with them and benefiting from their insights and experience.”
Dr. Altschuler, 55, is president and chief executive officer of The Children’s Hospital of Philadelphia, a position he has held since 2000. He joined Children’s Hospital in 1982 as a Fellow in the Division of Pediatric Gastroenterology and Nutrition. Currently, Dr. Altschuler serves on the Board of Directors of the Children’s Miracle Network. He holds a bachelor of arts in mathematics and statistics from Case Western Reserve University and earned his medical degree at Case Western University School of Medicine.
Dr. Sigal, 57, is currently the executive vice president, chief scientific officer and president, research and development for Bristol-Myers Squibb. Since joining Bristol-Myers Squibb in 1997, Dr. Sigal has held positions of increasing responsibility in genomics, discovery research and clinical development. He has more than 25 years of combined experience in medicine, research and management. Dr. Sigal received his medical degree from the University of Chicago and trained in Internal Medicine and Pulmonary Medicine at the University of California, San Francisco. Prior to medical school, he studied industrial engineering at Purdue University, where he received bachelor’s, master’s and doctorate degrees.
About Mead Johnson
Mead Johnson develops, manufactures, markets and distributes more than 70 products in 50 markets worldwide, primarily under the "Enfa" family of brands, including Enfamil® infant formula. For more information on Mead Johnson, go to www.meadjohnson.com.
Source: Mead Johnson
